- O-Desmethyltramadol
- O-DSMT
- Desmetramadol
Montenarh, D; Hopf, M; Warth, S; Maurer, HH; Schmidt, P; Ewald, AH. A simple extraction and LC-MS/MS approach for the screening and identification of over 100 analytes in eight different matrices: Detection of 130 analytes in eight biosamples using only one LC-MS/MS method. Drug Test. Anal., 1 Mar 2015, 7 (3), 214-240. 593 kB. https://doi.org/10.1002/dta.1657
Sommerfeld-Klatta, K; Teżyk, A; Geppert, B. Toxicological analysis of new opioids. In Chromatographic Techniques in the Forensic Analysis of Designer Drugs; Kowalska, T; Sajewicz, M; Sherma, J, Eds., CRC Press, Taylor & Francis Group, 1 Jan 2018; pp 391–417. 746 kB.
EMCDDA. New drugs in Europe, 2009, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2010. 321 kB. #12
Nakhaee, S; Hoyte, C; Dart, RC; Askari, M; Lamarine, RJ; Mehrpour, O. A review on tramadol toxicity: Mechanism of action, clinical presentation, and treatment. Forensic Toxicol., 1 Jul 2021, 39 (2), 293-310. 897 kB. https://doi.org/10.1007/s11419-020-00569-0
Angenoorth, TJF; Stankovic, S; Niello, M; Holy, M; Brandt, SD; Sitte, HH; Maier, J. Interaction profiles of central nervous system active drugs at human organic cation transporters 1–3 and human plasma membrane monoamine transporter. Int. J. Mol. Sci., 30 Nov 2021, 22 (23), 12995. 5.1 MB. https://doi.org/10.3390/ijms222312995 #O-Desmethyltramadol